Dr. Reddy's Laboratories Files Form 6-K
Ticker: RDY · Form: 6-K · Filed: Aug 2, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
DRL files 6-K, confirms 20-F filing, standard procedure.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 2, 2024, reporting as a foreign private issuer. The filing indicates the company will file its annual reports under Form 20-F. The company's principal executive office is located in Hyderabad, Telangana, India.
Why It Matters
This filing is a routine disclosure for foreign private issuers, confirming their reporting status and providing basic company information to the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain material new financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- Hyderabad, Telangana, India (location) — Principal executive office location
- August 2, 2024 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used for routine disclosures.
Which form does Dr. Reddy's Laboratories Ltd. use for its annual reports?
Dr. Reddy's Laboratories Ltd. indicates it files its annual reports under cover of Form 20-F.
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
The principal executive office of Dr. Reddy's Laboratories Ltd. is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the filing date of this Form 6-K?
This Form 6-K was filed on August 2, 2024.
Is Dr. Reddy's Laboratories Ltd. submitting this Form 6-K in paper format?
The filing does not indicate that the Form 6-K is being submitted in paper format under Regulation S-T Rule 101(b)(1) or 101(b)(7).
Filing Stats: 403 words · 2 min read · ~1 pages · Grade level 16.6 · Accepted 2024-08-02 06:05:46
Filing Documents
- drr0654_6k.htm (6-K) — 16KB
- drr0654_ex99-1.htm (EX-99.1) — 127KB
- drr0654_ex99-1img01.jpg (GRAPHIC) — 3KB
- drr0654_ex99-1img02.jpg (GRAPHIC) — 10KB
- drr0654_ex99-1img03.jpg (GRAPHIC) — 8KB
- 0001575872-24-000859.txt ( ) — 173KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 1, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3